rs754329335
Variant summary
Our verdict is Likely benign. Variant got -1 ACMG points: 2P and 3B. PM2BP4_ModerateBS1_Supporting
The NM_001271938.2(MEGF8):c.7631G>A(p.Arg2544Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000159 in 1,605,682 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_001271938.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MEGF8 | NM_001271938.2 | c.7631G>A | p.Arg2544Gln | missense_variant | 42/42 | ENST00000251268.11 | NP_001258867.1 | |
MEGF8 | NM_001410.3 | c.7430G>A | p.Arg2477Gln | missense_variant | 41/41 | NP_001401.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MEGF8 | ENST00000251268.11 | c.7631G>A | p.Arg2544Gln | missense_variant | 42/42 | 5 | NM_001271938.2 | ENSP00000251268 | A2 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152158Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000561 AC: 13AN: 231648Hom.: 0 AF XY: 0.0000704 AC XY: 9AN XY: 127782
GnomAD4 exome AF: 0.000173 AC: 251AN: 1453524Hom.: 0 Cov.: 31 AF XY: 0.000191 AC XY: 138AN XY: 722336
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152158Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74316
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 22, 2021 | The c.7430G>A (p.R2477Q) alteration is located in exon 41 (coding exon 41) of the MEGF8 gene. This alteration results from a G to A substitution at nucleotide position 7430, causing the arginine (R) at amino acid position 2477 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
MEGF8-related Carpenter syndrome Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 15, 2016 | In summary, this variant is a rare missense change with uncertain impact on protein function. There is no indication that it causes disease, but the available evidence is currently insufficient to prove that conclusively. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may alter RNA splicing, but this prediction has not been confirmed by published transcriptional studies. Algorithms developed to predict the effect of missense changes on protein structure and function do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0"). This variant is present in population databases (rs754329335, ExAC 0.04%) but has not been reported in the literature in individuals with a MEGF8-related disease. This sequence change replaces arginine with glutamine at codon 2477 of the MEGF8 protein (p.Arg2477Gln). The arginine residue is moderately conserved and there is a small physicochemical difference between arginine and glutamine. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at